MIT affiliates receive 2025 IEEE honors
Five MIT faculty and staff, along with five alumni, are honored for electrical engineering and computer science advances.
Download RSS feed: News Articles / In the Media / Audio
Five MIT faculty and staff, along with five alumni, are honored for electrical engineering and computer science advances.
Researchers at MIT, NYU, and UCLA develop an approach to help evaluate whether large language models like GPT-4 are equitable enough to be clinically viable for mental health support.
Five MIT faculty members and two additional alumni are honored with fellowships to advance research on beneficial AI.
Ten objects on display in the Koch Institute Public Galleries offer uncommon insights into the people and progress of MIT's cancer research community.
In a recent commentary, a team from MIT, Equality AI, and Boston University highlights the gaps in regulation for AI models and non-AI algorithms in health care.
The MIT Health and Life Sciences Collaborative will bring together researchers from across the Institute to deliver health care solutions at scale.
Marzyeh Ghassemi works to ensure health-care models are trained to be robust and fair.
Thomas Heldt, associate director of IMES, describes how he collaborates closely with MIT colleagues and others at Boston-area hospitals.
Novel method to scale phenotypic drug screening drastically reduces the number of input samples, costs, and labor required to execute a screen.
A research scientist and internationally recognized authority in the field of blood cell development reflects on 45 years at MIT.
Advisors commended for providing exceptional individualized mentoring for postdocs.
The innovations map the ocean floor and the brain, prevent heat stroke and cognitive injury, expand AI processing and quantum system capabilities, and introduce new fabrication approaches.
New statistical models based on physiological data from more than 100 surgeries provide objective, accurate measures of the body’s subconscious perception of pain.
MIT researchers find that the first dose primes the immune system, helping it to generate a strong response to the second dose, a week later.
MIT scientists’ discovery yields a potent immune response, could be used to develop a potential tumor vaccine.